If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRDL.L Regulatory News (RDL)

  • There is currently no data for RDL

C Share Issue

16 Nov 2015 14:46

RNS Number : 8694F
Ranger Direct Lending Fund PLC
16 November 2015
 

 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member states of the European Economic Area (other than the United Kingdom), Canada, Australia, Japan or South Africa.

 

16 November 2015

 

Ranger Direct Lending Fund PLC

(the "Company")

C Share Issue

 

Further to the announcement made by the Company on 10 November 2015, the Company is pleased to announce that it has today published a prospectus (the "Prospectus") relating to a placing and intermediaries offer for a target issue of 13.5 million C Shares at a price of £10.00 per C Share to raise £135 million (the "Issue").1

 

The Company is also pleased to announce the commencement of the intermediaries offer ("Intermediaries Offer") today under which retail investors can apply for C Shares through stockbrokers and share dealing providers who are participating as intermediaries. The Intermediaries Offer closes at 5:00 p.m. on 24 November 2015. 

 

A list of the firms acting as intermediaries for the Intermediaries Offer, and a copy of the Prospectus, will shortly be available on the Company's website at www.RangerDirectLending.com. Copies of the Prospectus are also available free of charge during normal business hours from the Company's registered office, 40 Dukes Place, London EC3A 7NH.

 

The Prospectus has been submitted to the National Storage Mechanism and will shortly be available at http://www.hemscott.com/nsm.do.

 

http://rangerdirectlending.com/documents/

 

For further information, please contact:

 

Capita Company Secretarial Services Limited

Secretary

 

+44 (0)20 7954 9569

Ranger Capital Group Bill Kassul

Scott Canon

 

via Redleaf PR 

Liberum Capital Limited

Simon Atkinson

Tom Fyson

Joshua Hughes

 

+44 (0)20 3100 2000

Media enquiries

Redleaf Communications

Rebecca Sanders-Hewett

Richard Gotla

David Ison

Susie Hudson

 

ranger@redleafpr.com

+ 44 (0)20 7382 4731

Intermediary Offer enquiries:

Scott Harris

Jeremy Wiseman

Jamie Blewitt

+44 (0)20 7653 0030

 

Expected Timetable

 

2015

Latest time and date for receipt of completed application forms from the Intermediaries in respect of the Intermediaries Offer

 

5.00 p.m. on 24 November

 

Latest time and date for commitments under the Placing

 

12.00 p.m. on 25 November

Publication of results of the Issue

 

26 November

Admission and commencement of dealings in the C Shares issued under the Issue

 

8.00 a.m. on 30 November

CREST accounts credited in respect of uncertificated C Shares issued under the Issue

 

8.00 a.m. on 30 November

Where applicable, share certificates despatched in respect of C Shares issued under the Issue

 

Week commencing 14 December

Times and dates are subject to change.

 

 

 

Issue Statistics

 

Target size of the Placing and Intermediaries Offer

 

£135 million1

Issue price per C Share for the Issue

 

£10

Target estimated Net Proceeds receivable by the Company

 

£133 million

 

 

IMPORTANT INFORMATION

 

This announcement which has been prepared by, and is the sole responsibility of, the Directors of the Company has been approved solely for the purposes of section 21 of the Financial Services and Markets Act 2000 by Liberum Capital Limited ("Liberum"), which is authorised and regulated by the Financial Conduct Authority.

 

This announcement is an advertisement and does not constitute a prospectus relating to the Company and does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer to subscribe for, any shares in the Company in any jurisdiction nor shall it, or any part of it, or the fact of its distribution, form the basis of, or be relied on in connection with or act as any inducement to enter into, any contract therefor. Copies of the prospectus published by the Company will be available from the Company's registered office.

 

Recipients of this announcement who are considering acquiring C Shares following publication of the prospectus are reminded that any such acquisition must be made only on the basis of the information contained in the prospectus which may be different from the information contained in this announcement. The subscription for C Shares is subject to specific legal or regulatory restrictions in certain jurisdictions. Persons distributing this announcement must satisfy themselves that it is lawful to do so. The Company assumes no responsibility in the event that there is a violation by any person of such restrictions.

 

This document may not be published, distributed or transmitted by any means or media, directly or indirectly, in whole or in part, in or into the United States. This document does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States. The securities mentioned herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "US Securities Act") or with any securities regulatory authority of any state or other jurisdiction of the United States and will not be offered, sold, exercised, resold, transferred or delivered, directly or indirectly, in or into the United States or to, or for the account or benefit of, any US person (as defined under Regulation S under the US Securities Act). The Company has not been, and will not be, registered under the U.S. Investment Company Act of 1940, as amended.

 

Neither this announcement nor any copy of it may be: (i) taken or transmitted into or distributed in any member state of the European Economic Area (other than the United Kingdom), Canada, Australia or the Republic of South Africa or to any resident thereof, or (ii) taken or transmitted into or distributed in Japan or to any resident thereof. Any failure to comply with these restrictions may constitute a violation of the securities laws or the laws of any such jurisdiction. The distribution of this announcement in other jurisdictions may be restricted by law and the persons into whose possession this document comes should inform themselves about, and observe, any such restrictions.

 

This announcement may include "forward-looking statements". All statements other than statements of historical facts included in this announcement, including, without limitation, those regarding the Company's financial position, business strategy, plans and objectives of management for future operations (including development plans and objectives relating to the Company's products and services) are forward-looking statements.

 

Forward-looking statements are subject to risks and uncertainties and accordingly the Company's actual future financial results and operational performance may differ materially from the results and performance expressed in, or implied by, the statements. These factors include but are not limited to those described in the formal prospectus. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect actual results or any change in the assumptions, conditions or circumstances on which any such statements are based unless required to do so by the Financial Services and Markets Act 2000, the Listing Rules or Prospectus Rules of the Financial Conduct Authority or other applicable laws, regulations or rules.

 

Liberum, which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting only for the Company in connection with the matters described in this announcement and is not acting for or advising any other person, or treating any other person as its client, in relation thereto and will not be responsible for providing the regulatory protection afforded to clients of Liberum or advice to any other person in relation to the matters contained herein. Neither Liberum nor any of its directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to the truth, accuracy or completeness of, the information in this announcement (or whether any information has been omitted from the announcement) or any information relating to the Company, whether written, oral or in a visual or electronic format, and howsoever transmitted or made available or any loss howsoever arising from any use of this announcement or its contents or otherwise in connection with it.

 

1The Directors have reserved the right, in consultation with Liberum, to increase the size of the Issue to up to 16.5 million C Shares if overall demand exceeds 13.5 million C Shares, with any such increase being announced through a Regulatory Information Service.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBSBDBSSBBGUL
Date   Source Headline
18th Jun 20187:30 amRNSBoard Changes
12th Jun 20183:09 pmRNSMonthly Update
12th Jun 20183:07 pmRNSNet Asset Value(s)
12th Jun 20187:00 amBUSOaktree Releases Open Letter to Shareholders: Changed Landscape Reinforces Need for Board Change
11th Jun 20183:35 pmRNSNotice of AGM
11th Jun 20187:00 amRNSManagement Review Process Update
8th Jun 20187:00 amBUSOaktree Releases Open Letter to Ranger Shareholders
6th Jun 20184:49 pmRNSResponse to Fourth Oaktree Letter
6th Jun 20187:11 amBUSOaktree Releases Open Letter to Ranger Shareholders
16th May 20184:31 pmRNSNotice of AGM
15th May 20182:46 pmRNSMonthly Update
15th May 20182:34 pmRNSNet Asset Value(s)
14th May 20183:51 pmRNSHolding(s) in Company
8th May 20187:00 amRNSResponse to Third Oaktree Letter
8th May 20187:00 amBUSOaktree Nominates Two Additional Directors for Upcoming Ranger Shareholder Annual General Meeting
4th May 20187:00 amBUSOaktree Releases an Open Letter to Ranger Shareholders following Proposal from RDL Board to Appoint Ares as Investment Manager
1st May 20187:47 amRNSManagement Review Update - Replacement
1st May 20187:18 amRNSManagement Review Update
30th Apr 20187:00 amRNSPortfolio Update
30th Apr 20187:00 amRNSAnnual Financial Report
27th Apr 201810:55 amRNSResponse to Second Oaktree Letter
27th Apr 20187:00 amBUSOaktree Sends Further Letter to Ranger Board of Directors
24th Apr 20182:58 pmRNSResponse to Oaktree
24th Apr 20181:54 pmBUSOaktree Sends Letter to Ranger Board of Directors Regarding Strategic Review
13th Apr 20182:43 pmRNSPortfolio Update
5th Apr 20184:40 pmRNSMonthly Update
5th Apr 20184:36 pmRNSNet Asset Value(s)
3rd Apr 20183:57 pmRNSHolding(s) in Company
3rd Apr 20183:56 pmRNSHolding(s) in Company
12th Mar 20187:48 amRNSPortfolio Update
6th Mar 20184:24 pmRNSMonthly Update
6th Mar 20184:20 pmRNSNet Asset Value(s)
1st Mar 20187:00 amRNSDividend Declaration
27th Feb 20183:06 pmRNSIFRS Implementation
23rd Feb 20182:49 pmRNSHolding(s) in Company
23rd Feb 20182:19 pmRNSHolding(s) in Company
6th Feb 20185:11 pmRNSMonthly Update
6th Feb 20185:09 pmRNSNet Asset Value(s)
6th Feb 20184:21 pmRNSHolding(s) in Company
29th Jan 20188:15 amRNSExternal Management & Princeton Arbitration Update
11th Jan 20184:43 pmRNSPortfolio Update
5th Jan 20183:47 pmRNSMonthly Update
5th Jan 20183:38 pmRNSNet Asset Value(s)
27th Dec 20173:44 pmRNSDirector/PDMR Shareholding
20th Dec 20174:22 pmRNSMonthly Update
20th Dec 20174:20 pmRNSNet Asset Value(s)
15th Dec 20173:38 pmRNSHolding(s) in Company
15th Dec 20177:00 amRNSPortfolio Update
14th Nov 20177:00 amRNSPrinceton - Portfolio Update
14th Nov 20177:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.